Letrozole, Pyrotinib Combined With SHR6390 in Patients With HR+/HER2+ Relapsed/Metastatic Breast Cancer
about
Letrozole, Pyrotinib Combined With SHR6390 in Patients With HR+/HER2+ Relapsed/Metastatic Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Letrozole, Pyrotinib Combined ...... apsed/Metastatic Breast Cancer
@en
type
label
Letrozole, Pyrotinib Combined ...... apsed/Metastatic Breast Cancer
@en
prefLabel
Letrozole, Pyrotinib Combined ...... apsed/Metastatic Breast Cancer
@en
P1476
Phase Ib/II Study of Letrozole ...... apsed/Metastatic Breast Cancer
@en
P3098
NCT03772353
P4844
P580
2018-12-12T00:00:00Z
P582
2019-11-12T00:00:00Z